We are live on ! Find out more
ZSPH

ZS PHARMA INC COMS TK (DE)
ZSPH

Delisted

ZSPH was delisted on the 16th of December, 2015.

65 hedge funds and large institutions have $293M invested in ZS PHARMA INC COMS TK (DE) in 2014 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,532% more capital invested

Capital invested by funds: $18M → $293M (+$275M)

713% more funds holding

Funds holding: 865 (+57)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
65
Holders Change
+57
Holders Change %
+712.5%
% of All Funds
1.89%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
57
Increased
3
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

ZSPH Hedge Fund Activity: Q3 2014 in Review

65 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q3 2014, worth a combined $293M — up 1,532% from $18M a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new ZSPH positions and 0 closed out — a net gain of 57 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $41.7M. The largest seller was Alyeska Investment Group, cutting an estimated $2.9M.

  • 65 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q3 2014, up from 8 in Q2 2014.
  • Funds reported $293M of ZS PHARMA INC COMS TK (DE) stock for Q3 2014, up 1,532% quarter-over-quarter.
  • 57 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q3 2014 and 0 closed out, a net change of +57 holders.
  • The largest ZS PHARMA INC COMS TK (DE) buyer in Q3 2014 was Fidelity Investments, an estimated $41.7M added.
  • The largest ZS PHARMA INC COMS TK (DE) seller in Q3 2014 was Alyeska Investment Group, an estimated $2.9M sold.

Based on aggregated 13F filings for Q3 2014.